Levetiracetam Oral Solution, USP, 100 mg/mL, packaged in a 16 fl oz (473 mL) bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Jeedimetla,Hyderabad - 500 055, India, NDC 31722-574-47
Published December 6, 2017 · Recall initiated: October 12, 2017
Summary
FDA records drug Class II recall D-0099-2018, published December 6, 2017 and initiated October 12, 2017. Recalling firm: Hetero Labs, Ltd. - Unit III; Status: Terminated; Reported quantity: 4050 bottles; Lot: Lot # E170346, Exp 02/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of foreign substance (screw)
What to do
Voluntary: Firm initiated · Letter
Get an email if LEVETIRACETAM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LEVETIRACETAM
- Manufacturer
- Hetero Labs, Ltd. - Unit III
- Distributor
- NJ
- UPC
- 0331722574471
- Lot
- Lot # E170346, Exp 02/19
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDALevetiracetam 0.75% in Sodium Chloride Injection 1,000 mg/100 mL (10 mg/mL), 1 x 100mL, Rx Only, ManufacturedApril 23, 2025
- FDALevetiracetam Tablets USP 750 mg 120-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279April 22, 2020
- FDALevetiracetam in 0.54% Sodium Chloride Injection, 1,500 mg per 100 mL (15 mg/mL), For Intravenous InfusionMay 9, 2018
- FDALevetiracetam in 0.82% Sodium Chloride Injection, 500 mg per 100 mL (5 mg/mL), For Intravenous Infusion Only,May 9, 2018
- FDALiothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distributed by Perrigo Minneapolis, MNDecember 6, 2017
- FDAVertra Elemental Resistance (Octyl Methoxycinnamate 6%, Oxybenzone 5%, Titanium Dioxide 6.3%, Zinc Oxide 9.9%)December 6, 2017
Questions about this recall
Was Levetiracetam Oral Solution, USP, 100 mg/mL, packaged in a 16 fl oz (473 mL) bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Jeedimetla,Hyderabad - 500 055, India, NDC 31722-574-47 recalled?
Yes. FDA published recall D-0099-2018 on December 6, 2017. Reported hazard: Presence of foreign substance (screw)
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LEVETIRACETAM. UPC: 0331722574471.